Longitudinal Prospective Natural History Study of Retinopathy in Zellweger Spectrum Disorder
Part of paid clinical trials in Rochester, New York.
- Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Study ID
- NCT06190626
- Status
- Recruiting
Conditions
- Zellweger Spectrum Disorder
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The goal of this observational study is to define the course of the retinal degeneration in a ZSD patient cohort. The objective of this study is to gather information so the investigators can: 1. define the course of the retinal degeneration in a ZSD patient cohort with retinal degeneration 2. define what tests best monitor the progression of the retinal degeneration 3. generate prognostic information about vision loss in ZSD. At each yearly visit, the participants will answer a functional vision questionnaire, have a physical evaluation, blood test, and participate in a variety of vision tests. The investigators will also collect pertinent medical history. Participants will travel to study site. The study will provide financial support for board and travel.
Key Dates
- Start date
- Dec 18, 2023
- Status verified
- Jan 2026
- Primary completion
- Jan 1, 2029
- Completion
- Jan 1, 2029
Study Design
- Enrollment
- 30 participants (estimated)
Primary Outcome Measure
Number of participants with disease progression [ Time Frame: 5 years ]
Central Contacts
- Nancy E Braverman, MD, MS514-934-1934
- Frederique Arnaud, BScN514-934-1934
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| University of Rochester Medical Center/Flaum Eye Institute | Rochester | New York | 14642 | Alex Levin, MD Alex Levin (PRINCIPAL_INVESTIGATOR) |